Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: Results of the European Heart Rhythm Association Survey

Europace

Volumn 16, Issue 2, 2014, Pages 293-298

  Potpara, Tatjana S ^a   Lip, Gregory Y H ^b   Dagres, Nikolaos ^c   Estner, Heidi L ^d   Larsen, Torben B ^e,f   Blomström Lundqvist, Carina ^g  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF ATHENS   (Greece)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

^f AALBORG UNIVERSITY   (Denmark)

^g UPPSALA UNIVERSITY   (Sweden)

Author keywords

Acute coronary syndrome; Anticoagulation; Atrial fibrillation; Dual antiplatelet therapy; EHRA survey; EP Wire; Guidelines; Novel oral anticoagulants; Triple therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APIXABAN; CLOPIDOGREL; DABIGATRAN; PRASUGREL; RIVAROXABAN; TICAGRELOR; WARFARIN;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; ARTICLE; EUROPE; EVIDENCE BASED PRACTICE; HEALTH CARE SURVEY; HEART ATRIUM FIBRILLATION; HUMAN; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNIVERSITY HOSPITAL;

ACUTE CORONARY SYNDROME; ANTICOAGULATION; ATRIAL FIBRILLATION; DUAL ANTIPLATELET THERAPY; EHRA SURVEY; EP WIRE; GUIDELINES; NOVEL ORAL ANTICOAGULANTS; TRIPLE THERAPY;

ACUTE CORONARY SYNDROME; ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EUROPE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HOSPITALS, UNIVERSITY; HUMANS; INTERNET; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84893287832     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu008     Document Type: Article

References (11)

1. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413.
2. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619.
3. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011;32:2999-3054.
4. Lamberts M, Olesen JB, Ruwald MH, Hansen CM, Karasoy D, Kristensen SL et al. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Circulation 2012;126:1185-93.
5. Bernard A, Fauchier L, Pellegrin C, Clementy N, Saint Etienne C, Banerjee A et al. Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation. Thromb Haemost 2013;110:560-8.
6. Lip G.Y., Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset Tet al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Thromb Haemost 2010;103:13-28.
7. Maŕn F, Huber K, Lip GY. Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy. Thromb Haemost 2013;110:623-5.
8. Heidbuchel H, Verhamme P, Alings M, Antz M, HackeW, Oldgren J et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 2013;15:625-51.
9. Dewilde WJ, Oirbans T, VerheugtFW, Kelder JC, De Smet BJ, Herrman JP et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 2013;381:1107-15.
10. Hohnloser SH, Oldgren J, Yang S,Wallentin L, Ezekowitz M, Reilly P et al. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial. Circulation 2012;125:669-76.
11. Smith JG, Wieloch M, Koul S, Braun OÖ , Lumsden J, Rydell E et al. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score. EuroIntervention 2012;8: 672-8.